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Huntington’s disease (HD) is a genetic, neurodegenerative disorder, which specifically
affects striatal neurons of the indirect pathway, resulting in a progressive decline in muscle
coordination and loss of emotional and cognitive control. Interestingly, predisposition to
pathological gambling and other addictions involves disturbances in the same cortico-
striatal circuits that are affected in HD, and display similar disinhibition-related symptoms,
including changed sensitivity to punishments and rewards, impulsivity, and inability
to consider long-term advantages over short-term rewards. Both HD patients and
pathological gamblers also show similar performance deficits on risky decision-making
tasks, such as the Iowa Gambling Task (IGT). These similarities suggest that HD patients
are a likely risk group for gambling problems. However, such problems have only
incidentally been observed in HD patients. In this review, we aim to characterize the risk
of pathological gambling in HD, as well as the underlying neurobiological mechanisms.
Especially with the current rise of easily accessible Internet gambling opportunities, it is
important to understand these risks and provide appropriate patient support accordingly.
Based on neuropathological and behavioral findings, we propose that HD patients may
not have an increased tendency to seek risks and start gambling, but that they do have
an increased chance of developing an addiction once they engage in gambling activities.
Therefore, current and future developments of Internet gambling possibilities and related
addictions should be regarded with care, especially for vulnerable groups like HD patients.
Keywords: Huntington’s disease, risk-taking, gambling, prefrontal cortex, basal ganglia, disinhibtion
INTRODUCTION
Huntington’s disease (HD) is a genetic neurodegenerative dis-
order, inherited in an autosomal dominant fashion. The disease
is characterized by progressive motor, cognitive and behavioral
symptoms, which usually become apparent between 30 and 50
years of age, and lead to premature death in 10–20 years after
disease onset. HD is caused by a mutation in the Huntingtin
gene (HTT), which leads to protein aggregation, deregulation
of several cellular processes, and eventually cell death. Neuronal
degeneration initially occurs selectively in the striatum (caudate
nucleus and putamen), where it affects cortico-striatal pathways
that serve to control motor and cognitive functions (Reiner et al.,
2011; Vonsattel et al., 2011). At the motor level, this degenerative
process is expressed as disorganized movements (chorea), while
at the cognitive/behavioral level patients display an “executive
dysfunction syndrome”, encompassing amongst others impulsiv-
ity, poor risk assessment and an inability to halt a poor course
of action (Hamilton et al., 2003; Duff et al., 2010b). Similar
behavioral and cognitive symptoms are seen in addictive behavior
related to substances or activities (Newman, 1987; Rosenblatt,
2007; Iacono et al., 2008). Therefore, it may be expected that HD
patients are at risk of developing addictions. Decision-making
paradigms in laboratory settings have indeed suggested deficits
in risky decision-making in advanced HD patients (e.g., Stout
et al., 2001), and pathological gambling has incidentally been
observed in this patient group (De Marchi et al., 1998). However,
these findings are rare, and surprisingly few studies have directly
examined symptoms and consequences of, for instance, behav-
ioral disinhibition in HD.
In this review we will argue that HD patients may be a risk
group for developing problematic gambling. Firstly, problematic
gambling is characterized by subjects’ inability to stop gam-
bling despite financial, personal or professional problems. Based
on neurobiological disturbances and behavioral symptoms the
capacity to stop gambling behavior seems diminished or absent in
HD patients. Secondly, due to the more liberal attitudes towards
gambling and increasing possibilities of legal and illegal Internet
gambling (see e.g., Griffiths, 2003), we may expect the occurrence
of gambling problems to increase in the coming years. Increased
accessibility may specifically pose a risk to vulnerable groups, such
as HD patients, that have not been previously exposed to such
risks.
In general, changing external conditions and treatment meth-
ods can have unexpected and undesirable effects on patient
behavior, especially in complex neurological diseases. Such effects
are easily missed when behavioral symptoms are not regularly
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reevaluated. This may be best illustrated by the case of Parkinson’s
disease, where the introduction of drug treatment with dopamine
agonists led to impulse control disorders such as compulsive
gambling, shopping, eating, and hypersexuality, caused by over-
stimulation of the mesolimbic dopaminergic system (Dodd et al.,
2005; Witjas et al., 2012; Weintraub et al., 2013). However, these
side effects were not recognized until years after the introduc-
tion of dopamine agonist therapies in combination with societal
changes related to (the availability of) shopping, food consump-
tion, sexuality, Internet, and gambling. This example illustrates
that reassessment of risk factors is important to be able to provide
effective treatment and guidance to patients in face of a changing
environment.
Here, we will explore the disease profile of HD in relation
to addiction, gambling problems, and decision-making deficits.
In Section HD: Neuropathology, Symptoms, and Progression, pro-
gression of HD symptoms will be discussed in relation to dis-
turbances in cortico-striatal circuits involved in task learning,
sensitivity to punishment, and cognitive/impulse control. In
Section Risk Taking and Pathological Gambling Behavior in HD,
the neurobiological profile of HD patients will be discussed in
the context of gambling and well-established risk-taking and
decision-making tests, such as the Iowa Gambling Task (IGT)
and the Cambridge Gambling Task (CGT). In Section Discussion,
we will discuss how a characterization of gambling risks may
lead to recommendations for HD patients and their caretak-
ers on how to deal with this issue and which situations are
best avoided. We also aim to identify yet unanswered ques-
tions, which may act as a starting point for future research
into the occurrence and risks of gambling problems in HD
patients.
HD: NEUROPATHOLOGY, SYMPTOMS, AND PROGRESSION
NEUROBIOLOGICAL DISEASE MECHANISMS
HD is caused by an unstable CAG (trinucleotide; cytosine-
adenine-guanine) repeat in the coding region of the HTT gene,
which leads to the production of mutant huntingtin protein (Htt)
with an expanded polyglutamine (polyQ) stretch (MacDonald
et al., 1993). The number of trinucleotide repeats is inversely
correlated to the age of onset of disease (Snell et al., 1993; Stine
et al., 1993). The majority of HD patients has 40–55 repeats
which causes typical adult-onset disorder, while expansions of
more than 70 repeats lead to juvenile onset disorder. Individuals
with fewer than 35 CAG repeats in the HTT gene will not
develop HD. Although the exact mechanisms of HD pathogenesis
remain unknown and cannot be discussed here in detail, they
involve the formation of protein aggregates by polyQ expanded
Htt, as well as the interaction of mutant Htt with numerous
proteins that are involved in energy metabolism, protein and
vesicle transport, and regulation of gene transcription (Li and
Li, 2004; Jones and Hughes, 2011). The resulting deregulation of
these cellular processes eventually leads to neuronal degeneration
through mechanisms involving excitotoxicity and apoptosis.
Neuronal degeneration is initially restricted to the basal gan-
glia, where the medium spiny neurons in the striatum (caudate
nucleus and putamen) are specifically affected (Vonsattel and
DiFiglia, 1998; Kassubek et al., 2004). The striatum receives its
main excitatory (glutamatergic) input from cortical areas, while
it receives its dopaminergic input from the substantia nigra.
The striatum has two main inhibitory (GABA-ergic) outputs:
a direct and an indirect pathway (Figure 1A). Striatal neurons
of the direct pathway project to the internal globus pallidus
(GPi), which in turn has inhibitory projections to the thalamus.
The thalamus gives rise to the main excitatory input to the
cortex. Thus, in effect, activation of the direct striatal pathway
inhibits GPi activity, which in turn disinhibits thalamocortical
activity, thereby facilitating movement and cognitive functions.
The indirect striatal pathway, on the other hand, projects to the
external GP (GPe), which in turn sends inhibitory projections
to the subthalamic nucleus (STN). The STN sends excitatory
projections to the GPi. Accordingly, activation of the indirect
striatal pathway thereby disinhibits the STN, allowing it to activate
the GPi, which in turn inhibits thalamocortical activity, sup-
pressing movement and cognitive functions. Adaptive behavior
results from a (delicate) balance of activity in the direct and
indirect pathway. Pathology in the indirect pathway is key to
HD and disrupts the balance in striatal control resulting in a
loss of inhibitory control over motor functioning and behav-
ior (Figure 1B; Albin et al., 1989; Alexander and Crutcher,
1990).
Cortico-basal ganglia circuits, encompassing connections
between cortical areas, striatal areas, pallidal areas and thalamic
areas, are organized in a parallel fashion subserving different
functions in the organization of behavior. As many excellent
reviews exist on the anatomy and function of these circuits
(e.g., Alexander et al., 1986, 1990; Alexander and Crutcher,
1990; Yin and Knowlton, 2006; Verny et al., 2007; Yin et al.,
2008; Haber and Knutson, 2010; Sesack and Grace, 2010), we
only highlight a few issues here conducive to our review. First,
roughly speaking a dorsal to ventral topographical organiza-
tion in both cortical and striatal areas exists. Thus, the dorsal
prefrontal areas are associated with dorsal striatal areas while
the more ventral prefrontal areas are associated with more ven-
tral striatal areas (including the nucleus accumbens). Second,
broadly three functionally different circuits may be described.
The sensorimotor circuit encompasses the sensorimotor stria-
tum (putamen) and sensorimotor cortices associated with the
execution of motor behavior. The associative/cognitive control
circuit involves the dorsolateral prefrontal cortex, anterior cin-
gulate cortex, and associative striatum (caudate nucleus). This
circuit is especially relevant for executive functioning, i.e., it is
involved in cognitive control, planning and working memory. In
addition it is involved in promoting long-term adaptive behavior
by reinforcing or stopping (punishing) instrumental behavior,
i.e., sequences of behavioral acts, learned in interaction with
the environment (Kravitz et al., 2012; Paton and Louie, 2012).
The limbic circuit includes the orbitofrontal cortex, ventrome-
dial prefrontal cortex, amygdala, and limbic striatum (nucleus
accumbens). This circuit is especially relevant for evaluating
the affective value of stimuli, signaling the expected reward or
punishment of an upcoming stimulus, choice or event, emo-
tional control, and adaptive (emotional) learning (O’Doherty
et al., 2001; Rushworth et al., 2007; van den Bos et al., 2013b,
2014).
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FIGURE 1 | (A) Simplified scheme of the organization of cortico-basal
ganglia networks (cortical, striatal, pallidal and thalamic areas) showing the
direct and indirect pathways in normal brains. (B) Specific degeneration of
the indirect pathway (X) in HD leads to a decrease in inhibitory control over
cortical functions. GPe: external globus pallidus; GPi: internal globus
pallidus; STN: subthalamic nucleus. Red: inhibitory (GABA) pathways, Blue:
excitatory (glutamate) pathways.
Pathology in HD is observed in both the putamen and caudate
nucleus (Vonsattel and DiFiglia, 1998; Kassubek et al., 2004;
Vonsattel, 2008; Vonsattel et al., 2011; Hadzi et al., 2012). In addi-
tion, in both structures atrophy follows a characteristic pattern,
starting in the dorsal and caudal regions and moving towards the
ventral and rostral regions as the disease progresses (Vonsattel and
DiFiglia, 1998; Kassubek et al., 2004; Vonsattel, 2008). However
early atrophy has also been observed in the nucleus accumbens
and globus pallidus in some studies (van den Bogaard et al., 2011;
Sánchez-Castañeda et al., 2013). While disturbances in the senso-
rimotor circuit (putamen) may be related to the motor symptoms,
disturbances in the associative/cognitive control circuit (caudate
nucleus) may be related to executive dysfunction, and cause
deficits in e.g., working memory in early HD patients (Lawrence
et al., 1996; Bonelli and Cummings, 2007; Wolf et al., 2007).
Disturbances in the limbic circuit, such as due to early atrophy in
the nucleus accumbens, may be related to apathy and depression
(Bonelli and Cummings, 2007; Unschuld et al., 2012). Progressive
atrophy in the striatum may lead to a successive dysfunction of
cortico-striatal circuits. For instance, the ventral caudate nucleus
is also part of the orbitofrontal circuit, which is affected as
the disease progresses. Dysfunction of this circuit is related to
behavioral disinhibition (Bonelli and Cummings, 2007). Even-
tually, degeneration may spread to other brain areas, including
other parts of the basal ganglia (pallidal areas and thalamus),
hippocampus, amygdala and cortical areas at the late stages of the
disease.
In sum, HD is characterized by a specific degeneration of
striatal neurons belonging to the indirect pathway. As the disease
progresses, atrophy of the striatum spreads along a caudal-rostral
and dorsal-ventral gradient causing a sequential disturbance of
cortico-striatal circuits. The resulting loss of inhibitory control
in these circuits is directly related to the progression of motor,
cognitive and behavioral symptoms in HD, as discussed below.
SYMPTOMS OF HD
HD is characterized by a variety of progressive motor, cognitive
and behavioral symptoms. The first symptoms usually arise at
mid-age, with an average onset age of 40, although a small
percentage of patients suffer from juvenile-onset HD, which starts
before the age of 20. As the symptoms and progression of juvenile-
onset HD are somewhat distinct from adult-onset disorder, we
will focus on the latter patient group in this review. One of the
first symptoms to become apparent in HD is chorea (involuntary
movement disorder), and a clinical diagnosis is usually made
after onset of movement abnormalities (Shannon, 2011). Some
studies, however, report subtle cognitive and emotional changes
before onset of motor symptoms, and the exact order of occur-
rence and progression of HD symptoms remains a subject of
debate. Nevertheless, several comprehensive reviews of the clinical
manifestations of HD are available (Roos, 2010; Anderson, 2011;
Shannon, 2011).
Motor symptoms
Motor symptoms start to become apparent in the early stages of
HD, and are usually the first symptoms to be noticed in laboratory
settings and by first-degree relatives of HD patients (de Boo
et al., 1997; Kirkwood et al., 1999, 2001). Motor disturbances
appear to begin as a dysfunction in error feedback control (Smith
et al., 2000), consistent with the role of the cortico-striatal motor
circuit in sensorimotor learning and control (Graybiel et al.,
1994). The first signs of motor abnormalities are often subtle
involuntary movements (chorea) of e.g., facial muscles, fingers
and toes (“twitching”), hyperreflexia, and exaggerated voluntary
movements (Young et al., 1986; Shannon, 2011), which lead to
a general appearance of restlessness and clumsiness in early HD
patients. These abnormal movements are subtle and often go
unnoticed at first, but gradually worsen and spread to all other
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muscles over time. Other early motor symptoms include slow
or delayed saccadic eye movements (Peltsch et al., 2008) and
dysarthria (Ramig, 1986; Young et al., 1986). Dysarthria, a motor
speech disorder, leads to difficulty with articulation and slurring
of words, which makes speech progressively more difficult to
understand. Dysphagia (swallowing difficulties) is observed in
most patients with an onset at mid-disease stages, and gradually
worsens until patients can no longer eat unassisted and often
require a feeding tube in late-stage HD (Heemskerk and Roos,
2011). Other, non-choreic motor symptoms that usually become
apparent at mid-stage disease include complex gait disorder, pos-
tural instability, and dystonia (involuntary muscle contractions
that cause slow repetitive movements and abnormal postures),
which is often accompanied by frequent falls (Koller and Trimble,
1985; Tian et al., 1992; Louis et al., 1999; Grimbergen et al., 2008).
Rigidity and bradykinesia (slowness of movement and reflexes)
are sometimes observed, but are mostly restricted to cases of
juvenile-onset HD (Bittenbender and Quadfasel, 1962; Hansotia
et al., 1968). These motor symptoms are consistent with dys-
function of the sensorimotor (and associative/cognitive control)
cortico-striatal circuits that are commonly affected in HD.
Behavioral and psychiatric symptoms
Behavioral disorders in HD can be complex and difficult to
classify, and their occurrence and onset is highly variable between
individuals. Moreover, it can sometimes be difficult to distinguish
behavioral disorders from normal coping with a distressing dis-
ease (Caine and Shoulson, 1983). The number of studies that
have characterized behavioral symptoms in HD is limited, and as
a result there is relatively little insight in their prevalence in the
disease (van Duijn et al., 2007). The most frequently and consis-
tently reported behavioral and emotional symptoms in HD are
irritability, apathy, and depression, which occur with a prevalence
of approximately 50% (Caine and Shoulson, 1983; Folstein and
Folstein, 1983; Craufurd et al., 2001; Kirkwood et al., 2001; van
Duijn et al., 2007, 2014; Tabrizi et al., 2009). Both irritability
and apathy are sometimes observed in pre-manifest HD patients
(Tabrizi et al., 2009; van Duijn et al., 2014), and also depression
has been reported at early clinical stages (Shiwach, 1994; Julien
et al., 2007; Epping et al., 2013). These affective symptoms are
among the first non-motor symptoms to be noticed by first-
degree relatives (Kirkwood et al., 2001). Typical apathy-related
symptoms, which gradually become worse during the course of
the disease, include lack of energy, motivation and initiative,
decreased perseverance and quality of work, impaired judgment,
poor self-care and emotional blunting (Craufurd et al., 2001;
Kirkwood et al., 2001). Depressive symptoms have been related to
increased activity in the ventromedial prefrontal cortex (Unschuld
et al., 2012). Irritability is associated with orbitofrontal circuit
dysfunction, which leads to decreased control over emotional
responses in the amygdala (Klöppel et al., 2010).
Other, less commonly observed psychiatric symptoms and dis-
orders in HD are anxiety, obsessive-compulsive disorder, mania,
schizophrenia-like psychotic symptoms, such as paranoia, hallu-
cinations, and delusions (Caine and Shoulson, 1983; Folstein and
Folstein, 1983; Craufurd et al., 2001; Kirkwood et al., 2001; van
Duijn et al., 2007). These symptoms usually don’t occur until mid
or late stages of the disease, although they have incidentally been
reported to occur in preclinical HD patients (Duff et al., 2007).
Obsessive-compulsive disorder has been associated with damage
to the orbitofrontal cortex and anterior cingulate cortex, while
schizophrenia, a disorder which involves deficits in organizing,
planning and attention, is related to dorsolateral prefrontal cortex
dysfunction (Tekin and Cummings, 2002).
It is suggested that most psychiatric symptoms in HD are in
fact part of a broad, ill-defined “frontal lobe syndrome” or “exec-
utive dysfunction syndrome”, which includes symptoms such as
apathy, irritability, disinhibition, impulsivity, obsessiveness, and
perseveration (Lyketsos et al., 2004; Rosenblatt, 2007), all of
which are commonly observed in HD patients (Hamilton et al.,
2003; Duff et al., 2010b). Taken together, the literature indicates
that onset and progression of behavioral symptoms in HD is
heterogeneous, with affective disorders occurring most often and
with early onset, while anxiety, obsessive-compulsive disorder,
and psychotic symptoms are less common and usually occur later
in the disease. These psychiatric symptoms are associated with
dysfunction of limbic and associative/cognitive control cortico-
striatal circuits that are commonly affected in HD.
Cognitive symptoms
Cognitive decline is another important aspect of HD pathology.
Many studies have focused specifically on the occurrence of
cognitive symptoms in preclinical and early clinical stages of HD,
in the hope to discover early clinical biomarkers of the disease
(reviewed in Papp et al., 2011; Dumas et al., 2013). Overall, results
suggest that subtle cognitive changes may be observed up to 5–10
years before onset of motor symptoms with sufficiently sensitive
methods. One study even found that, at preclinical and early
clinical stages of HD, about 40% of patients already meet the
criteria for mild cognitive impairment (a disorder associated with
limited memory loss, not meeting the criteria for diagnosis of
dementia; Duff et al., 2010a). However, not all studies support
these findings (Blackmore et al., 1995; Giordani et al., 1995; de
Boo et al., 1997; Kirkwood et al., 2001). In general, the litera-
ture agrees that information processing and psychomotor speed
are especially affected at this early stage (Rothlind et al., 1993;
Kirkwood et al., 1999; Verny et al., 2007; Paulsen et al., 2008).
Other commonly observed early cognitive impairments include
problems with attention, (working) memory, and visuospatial
performance (Jason et al., 1988; Rothlind et al., 1993; Foroud
et al., 1995; Lawrence et al., 1996; Hahn-Barma et al., 1998; Verny
et al., 2007; Paulsen et al., 2008; Tabrizi et al., 2009; Papp et al.,
2011; Stout et al., 2011). Cognitive inflexibility has been observed
in early disease patients (Jason et al., 1988), at which stage
extra-dimensional shifts are specifically impaired, while reversal
learning is still intact (Lawrence et al., 1996). Thus, patients are
still able to reevaluate stimulus value and learn new stimulus-
reward contingencies within the same dimension (e.g., shape or
color), but have problems shifting their attention to a different
dimension (e.g., from color to shape) as required by the new
task rule to obtain reward. In later stages of the disease, cognitive
inflexibility and perseveration also cause impaired reversal learn-
ing in HD patients (Josiassen et al., 1983; Lange et al., 1995). This
progression of symptoms is consistent with specific dysfunction of
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the dorsolateral prefrontal circuit early in the disease, since extra-
dimensional set shifting is mediated by the dorsolateral prefrontal
cortex, while reversal learning is mediated by the orbitofrontal
cortex (Dias et al., 1996; McAlonan and Brown, 2003). Other early
impairments include disorganized behavior, impaired planning,
poor judgment, and reduced behavioral and emotional control
(Watkins et al., 2000; Paradiso et al., 2008; Duff et al., 2010b).
Disinhibition has been observed in early HD patients, whose
performance is impaired on tasks that require inhibition of pre-
potent but inappropriate responses (Holl et al., 2013). Finally, sev-
eral studies have found that preclinical HD patients are impaired
in the recognition of negative emotions such as anger, disgust, fear
and sadness. Emotional recognition declines progressively, and
can spread to problems with neutral emotions in early clinical
stages of the disease (Johnson et al., 2007; Tabrizi et al., 2009;
Labuschagne et al., 2013). This phenotype is related to dysfunc-
tion of the orbitofrontal cortex, which is involved in processing
emotional and reward information (Henley et al., 2008; Ille et al.,
2011).
Studies with animal models of HD show similar cognitive
impairments to those observed in human patients. Although
not all studies find robust cognitive deficits (Fielding et al.,
2012), findings in rat and mouse models of HD include anxi-
ety, increased responsiveness to negative emotional stimuli, and
impairments in reversal learning and strategy shifting (Faure
et al., 2011; Abada et al., 2013). One study found specific early
deficits in reversal learning before onset of motor symptoms in
a rat model of HD (Fink et al., 2012). Interestingly, HD animals
appear to have an increased responsiveness to negative emotional
stimuli, while human patients show decreased recognition of
negative emotions. At present it is unclear whether this reflects
differences in task administered (recognizing emotions versus
behavioral responses to threatening stimuli), species-related dif-
ferences in the outcome of pathology or a fundamental difference
between the rat model and the human condition. In general, stud-
ies in both human patients and animal models of HD demonstrate
that a wide range of cognitive functions can already be impaired in
early HD. Early abnormalities mainly include deficits in attention,
memory, cognitive flexibility, and emotional recognition. At this
early stage, patients often have impaired awareness of their own
(decline in) cognitive abilities (Hoth et al., 2007). Over time,
cognitive symptoms progressively get worse, eventually leading to
severe subcortical dementia in late stages of the disease. Although
the occurrence of symptoms is generally consistent with successive
impairment of associative/cognitive control and limbic cortico-
striatal circuits, respectively, specific functions that are related to
the limbic circuit can also already be affected at early-stage HD.
Conclusion
Motor, behavioral and cognitive symptoms in HD have been
studied extensively in the past, and continue to be a topic of
interest due to the wide variety and variability in the occur-
rence and onset of these symptoms across patients. In general,
behavioral and cognitive symptoms are related to three frontal
behavioral categories: apathy, executive dysfunction, and disinhi-
bition. The combination of these symptoms is sometimes referred
to as “executive dysfunction syndrome”. All of these symptoms
are related to deficits in the cortico-striatal circuits involving the
orbitofrontal cortex, dorsolateral prefrontal cortex and anterior
cingulate cortex. As discussed above, neuropathological studies
have observed a gradual degeneration of the striatum in a dorsal
to ventral direction in HD patients. Although the behavioral and
cognitive observations partly agree with a progressive impairment
of cortico-striatal circuits, the symptomatic findings appear to be
more diffuse than expected based on pathological observations.
Onset and progression of behavioral and cognitive symptoms in
HD is highly heterogeneous, indicating that damage to striatal
regions may be more variable and widespread in early stages of
HD than previously thought. This view is supported by evidence
from several structural imaging studies (Thieben et al., 2002;
Rosas et al., 2005; van den Bogaard et al., 2011).
RISK TAKING AND PATHOLOGICAL GAMBLING
BEHAVIOR IN HD
PATHOLOGICAL GAMBLING
While many people are able to gamble recreationally, it may
become an overt problem for some, as they develop pathological
forms of this behavior. Pathological gambling is characterized
by an excessive urge to gamble despite clear negative financial,
personal and professional consequences. It has recently been clas-
sified as an addiction in DSM-V, as it closely resembles substance
abuse disorders in both diagnostic criteria and neuropathology
(van Holst et al., 2010; Clark and Goudriaan, 2012). Pathological
gambling will be the first and only “behavioral addiction” rec-
ognized within the category “Addiction and Related Disorders”.
Nevertheless, it should be noted that differences exist between
addiction to psychoactive substances and addiction to gambling.
First, satisfying craving for psychoactive substances lies in con-
suming the substance of which the effect is known, while satisfy-
ing the craving for gambling may have an uncertain outcome as
money may be won or not, unless, it is the act of gambling itself,
for instance as an exciting activity. Thus, pathological gambling
may be more heterogeneous in this respect with also a more
uncertain outcome than substance abuse. It should be noted
that outcome variability, including both wins and losses, may be
crucial to the development of gambling addiction, as it presents
a variable intermittent pattern of reinforcement, which is the
most powerful form of instrumental/classic conditioning (Sharpe,
2002; Fiorillo et al., 2003). Second, psychoactive substances may
more strongly change activity in the brain and peripheral nervous
system than gambling, due to their direct pharmacological activity
at several neurotransmitter systems, accelerating thereby addictive
processes, making substance abuse a more powerful form of
addiction.
The underlying neurobiological mechanisms of gambling are
complex and involve many different brain regions and neuro-
transmitter systems (reviewed in Raylu and Oei, 2002; Goudriaan
et al., 2004; Potenza, 2013). Predisposition to addiction has been
related to a reduced level of dopamine D2 receptors in the
striatum, which function in a feedback loop to inhibit further
dopamine release. The resulting hyperactivity of dopaminergic
pathways increases sensitivity to reward, motivation, and positive
reinforcement of the addictive behavior (Volkow et al., 2002; Di
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Chiara and Bassareo, 2007). Specific motivational changes that
occur when pathological gambling develops include increased
motivation to gamble (van Holst et al., 2012) and enhanced
attention to gambling-related stimuli (Brevers et al., 2011a,b). In
addition, pathological gamblers have reduced cognitive control
over behavior in general, as exemplified by decreased performance
on response inhibition tasks, increased impulsivity, and a prefer-
ence for immediate over delayed rewards in neurocognitive tasks
(Goudriaan et al., 2004; Brevers et al., 2012a; van den Bos et al.,
2013a).
Pathological gamblers perform poorly compared to con-
trols on formal reward-related risky decision-making tasks (e.g.,
Cavedini et al., 2002; Brand et al., 2005; Brevers et al., 2012b;
review: Brevers et al., 2013). This poor performance is indepen-
dent of whether tasks contain explicit and stable rules for wins
and losses such as the Game of Dice Task (Brand et al., 2005) or
whether subjects have to learn by trial-and-error which choices
are advantageous in the long run, such as the IGT (Cavedini
et al., 2002; Brevers et al., 2012b; see Section Risky Decision-
Making by HD Patients on Laboratory Tasks for details of this
task). However, gambling severity was rather correlated with
performance on decision-making tasks in which probability of
outcome is unknown (IGT) than with tasks with explicit rules
(Brevers et al., 2012b). This observation is interesting in view
of the fact that in normal subjects the second half of the IGT
when subjects have learned task contingencies is akin to tasks
with explicit rules. Collectively, these data therefore suggest that
in pathological gambling impairments in decision-making may
result from both decreased executive control, which is related
to more explicit rules, and disturbed reward-punishment (emo-
tional) processing, which is more related to trial-and-error learn-
ing to assess long-term value of options (van den Bos et al.,
2013a, 2014). In addition, it suggests that disturbances in the
latter may be a predisposing factor to escalation of gambling
behavior.
From these studies it is clear that neurobiological predisposi-
tion for developing pathological gambling behavior involves dis-
turbances in both the associative/cognitive control circuit and the
limbic circuit (van den Bos et al., 2013a). As a result, pathological
gamblers display reduced cognitive control, increased impulsivity,
and increased sensitivity to reward, all of which are aspects of
behavioral disinhibition (Iacono et al., 2008). The chance that
an individual develops an addiction in its life, however, also
depends on many other aspects, such as early-life experiences and
environmental risks.
PATHOLOGICAL GAMBLING IN HD: EPIDEMIOLOGICAL EVIDENCE
With the increasing amount of possibilities offered by the Inter-
net, there has also been a rise in both legal and illegal online
gambling opportunities in recent years. These easily accessible and
often uncontrolled gambling activities may pose a risk to anyone
who has an increased susceptibility to gambling addiction, but
may otherwise not become involved in such activities (Griffiths,
2003). HD patients are one of the groups for which Internet gam-
bling may pose such a risk, because behavioral disinhibition—
a common feature in the disease—is an important factor in
the development of addictions (Iacono et al., 2008). Indeed, as
mentioned above, HD patients show several signs of disinhibition,
such as irritability, impaired response inhibition, and reduced
emotional recognition, at an early stage in the disease. Other
symptoms that have been observed in HD, and can influence
patients’ ability to make rational decisions, are cognitive inflexi-
bility, perseveration, poor judgment, and reduced self-awareness.
Besides these symptomatic similarities between HD patients and
pathological gamblers, both groups display structural and func-
tional abnormalities in similar cortico-striatal circuits.
In view of these similarities between pathological gamblers and
HD patients, we may expect the incidence of gambling problems
to be increased among HD patients compared to the normal
population. Nevertheless, only one study so far has reported cases
of pathological gambling in an Italian family with HD (De Marchi
et al., 1998). In this family, two individuals were diagnosed with
pathological gambling around the age of 18, well before the onset
of clinical signs of HD. Other epidemiological studies have not
reported on this issue, although impaired decision-making, risk
taking, and poor judgment have been shown to pose a risk for HD
patients handling important life decisions and financial affairs
(Klitzman et al., 2007; Shannon, 2011). Similarly, reports on
related issues such as substance abuse and addiction to Internet
use are missing in the current literature on HD pathology. At this
moment, it is unclear whether the absence of reports of gambling
problems in the HD literature is caused by a lack of attention
for this phenomenon, or whether there really is no increased
prevalence of pathological gambling among HD patients. Several
reasons may explain why such problems have not been reported
more frequently. Firstly, even if the incidence of pathological
gambling is increased in HD, this will likely still only affect a
small percentage of patients. In combination with the fact that
the HD-affected population itself is limited in number, this may
cause gambling problems to go unnoticed as a specific issue in
this patient group. Secondly, the lack of gambling problems in
HD may be related to the inability or unwillingness of patients to
leave the house due to motor disorders and frequently observed
signs of apathy and depression. Before the advent of Internet
gambling, this may have kept HD patients from visiting public
gambling places like the casino. Finally, adolescence appears to
be a sensitive period for developing gambling problems (van den
Bos et al., 2013a), while most HD patients do not start to show
disinhibition-related symptoms until later in life. However, with
the rise of Internet-related activities of adolescents, they may
acquire forms of recreational behavior such as online gambling,
which develop into a problem when HD symptoms become
manifest later in life. Thus, while the environment in which
gambling-susceptible HD patients find themselves may not have
promoted such behavior in the past, it is clear that an increased
accessibility and availability of gambling opportunities from the
home may change the prevalence of related problems in the HD
population.
RISKY DECISION-MAKING BY HD PATIENTS ON LABORATORY TASKS
Laboratory tasks are commonly used to assess cognitive and
behavioral abnormalities in neurological disorders. To gain
insight into the processes and impairments involved in decision-
making and risk-taking behavior, several tasks have been
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developed, including the IGT (Bechara et al., 1994) and the CGT
(Rogers et al., 1999). On the IGT, participants are presented with
four decks of cards. They are instructed to choose cards from
these decks, with which they can win or lose money; the goal of
the task is to win as much money as possible. The decks differ
from each other in the frequency and amount of wins and losses.
Two of these are “bad” decks, leading to an overall loss in the
long run, and two are “good” decks, leading to an overall gain.
The participants are not given this information, however, and
need to discover which decks are most advantageous during the
experiments. Normal, healthy, participants successfully learn the
rules of the task after a certain amount of sampling, and eventually
start to prefer the two “good” decks. Nevertheless, there are signif-
icant individual differences in performance even among healthy
participants, including for example clear sex differences (van den
Bos et al., 2013b). On the CGT, participants are presented with
a row of 10 boxes of two different colors, and need to make
a probabilistic decision in which color box a token is hidden.
They must then gamble credit points on their confidence in this
decision. In this task, all relevant information is presented to the
participant during the experiment, and trials are independent,
thus minimizing working memory and learning demands. Both
gambling tasks are well established, and the IGT is accepted as a
valid simulation of real-life decision-making (Buelow and Suhr,
2009), while the CGT is especially useful for studying decision-
making outside a learning context.
HD patients have been tested on both the Iowa and Cambridge
Gambling Task. In a study with intermediate-stage patients, Stout
et al. (2001) found that performance on the IGT was reduced
compared to normal subjects. The difference in performance
became apparent in the second part of the task; where sub-
jects normally start to show a preference for the good decks,
HD patients continued to make frequent selections from the
bad decks. This suggests that HD patients either did not learn
which decks were advantageous, or continued to choose cards
from the bad decks despite this knowledge. The authors noted
that several HD participants indicated to know that some decks
were disadvantageous, but still continued to select cards from
those decks, suggesting that HD patients can learn the rules of
the task, but are not able to enforce an advantageous selection
pattern and resist responding to individual punishments and
rewards. Nevertheless, reduced performance was found to be
associated with impaired memory and conceptualization, leading
the authors to speculate that HD patients may have trouble
learning or remembering the long-term consequences of choosing
cards from a particular deck. HD patients also scored higher on
disinhibition than healthy controls, but this measure was not
correlated with task performance. In a follow-up of the same data
Stout and colleagues, compared three cognitive decision models
to explain the performance deficit of HD patients, and found that
this was best explained by deficits in working memory and by
increases in recklessness and impulsivity (Busemeyer and Stout,
2002). Impaired performance of HD patients on the IGT may
also be related to a reduced impact of losses on these patients,
which was found by measuring skin conductance responses dur-
ing the IGT (Campbell et al., 2004). This finding is consistent
with impaired recognition of negative emotions in HD patients
(Johnson et al., 2007; Ille et al., 2011), and suggests that they
may be less sensitive to large punishments, and therefore less
likely to turn away from the bad card decks. Especially the second
part of the IGT requires the ability to suppress disadvantageous
courses of action in response to punishments, while reinforcing
profitable actions (de Visser et al., 2011; van den Bos et al., 2013b,
2014).
A limited number of other studies have tested risky decision-
making in early stages of HD, but did not find performance dif-
ficulties in these patients on either the IGT or the CGT (Watkins
et al., 2000; Holl et al., 2013). Thus, it appears that impairments
in decision-making and risk of gambling problems do not develop
until intermediate stages of the disease. However, these studies did
find impairments in tasks that required planning and inhibition
of pre-potent responses in early HD patients. It thus appears
that HD patients first develop subtle problems with inhibition,
planning, emotional recognition, and working memory. In some
patients this can already lead to problems with judgment and
decision-making in early stages of the disease, but most HD
patients don’t have problems with risky decision-making tasks
until they reach an intermediate stage of the disease.
NEUROBIOLOGICAL MECHANISMS OF DECISION MAKING IN HD
Neurobiological pathways underlying normal decision-making
processes in the IGT
The neurobiological mechanisms underlying decision-making
processes in the IGT have been well studied and described (see
e.g., Bechara et al., 2000; Doya, 2008; de Visser et al., 2011; van den
Bos et al., 2013b, 2014). Normal execution of this task requires an
interaction between the limbic and associative/cognitive control
cortico-striatal circuits. Activity in the limbic circuit is thought
to be dominant during the first phase of the IGT, during which
it is involved in exploratory behavior, responding to rewards
and punishments, and learning the affective values of short- and
long-term outcomes of decisions in the task (Manes et al., 2002;
Clark and Manes, 2004; Fellows and Farah, 2005; Gleichgerrcht
et al., 2010; de Visser et al., 2011; van den Bos et al., 2014). The
associative/cognitive control circuit, on the other hand, is more
important during the second part of the IGT, when it is necessary
to suppress impulsive responses to rewards and punishments for
long-term benefit, reinforce advantageous behavioral patterns
and suppress disadvantageous patterns (Manes et al., 2002; Clark
and Manes, 2004; Fellows and Farah, 2005; Gleichgerrcht et al.,
2010; de Visser et al., 2011; van den Bos et al., 2014).
Neurobiological abnormalities in IGT decision-making
processes in HD
Since decision-making processes in the IGT involve an interac-
tion of limbic and associative/cognitive control cortico-striatal
circuits, it is not surprising that HD patients are impaired in
the performance of this task. One of the observations by Stout
and colleagues is that the impact of loss on decision-making is
reduced in HD patients (Campbell et al., 2004). This is consistent
with findings that these patients are impaired in the recognition
of negative emotions, and may be explained by disturbances
in the orbitofrontal cortex (Ille et al., 2011). The orbitofrontal
cortex is important for emotional processing, and is activated in
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normal subjects in response to punishments and rewards in a
decision-making task (O’Doherty et al., 2001). Another finding
by Stout et al. (2001) is that the performance of HD patients on
the IGT is correlated with decreased conceptualization and long-
term memory measures on the Mattis Dementia Rating Scale.
A failure to learn or remember which decks are advantageous
on the long-term may be associated with decreased activity of
the associative/cognitive control circuit, which is required for
long-term planning and impulse control (Manes et al., 2002;
Clark and Manes, 2004; Fellows and Farah, 2005; Gleichgerrcht
et al., 2010). This is also consistent with specific deficits of the
indirect pathway in HD, since a recent study shows that the
indirect pathway is important for sensitivity to punishment in a
reinforcement-learning task (Kravitz et al., 2012; Paton and Louie,
2012). Insensitivity to the future consequences of a decision may
also be caused by ventromedial prefrontal cortex dysfunction,
since similar insensitivity is observed in patients with damage
to this prefrontal area (Bechara et al., 1994). Thus, decreased
performance of HD patients on the IGT may be caused by a
combination of dysfunctions in cortico-striatal circuits involv-
ing the orbitofrontal cortex, ventromedial prefrontal cortex and
dorsolateral prefrontal cortex. This leads to reduced responsive-
ness to punishment in the first phase of the task, and failure
to learn which decks are long-term advantageous, plan accord-
ingly, and suppress impulsive responses in the second phase of
the IGT.
DISCUSSION
HD AND PATHOLOGICAL GAMBLING: WHAT ARE THE RISKS?
The typical array of motor, emotional, and cognitive symptoms
of HD is caused by progressive striatal atrophy that affects the
different cortico-striatal circuits. Although onset and progression
of behavioral and cognitive symptoms appear to be highly het-
erogeneous, motor and cognitive circuits are typically affected
early in the disease, while the limbic circuit is affected at a later
stage. Interestingly, neurobiological predisposition to pathologi-
cal gambling and other addictions involves disturbances in the
same cortico-striatal circuits that are affected in HD. Despite
these striking similarities, however, in the medical literature HD
has not been associated with pathological gambling or other
addictive behaviors. Only one study so far has described a family
in which gambling problems occurred in several HD-affected
family members (De Marchi et al., 1998). We speculate that
patients’ motor symptoms, as well as their age and social envi-
ronment, may thus far have prevented them from developing
pathological gambling, despite their increased susceptibility to
such problems. On the other hand, the frequently diagnosed
depression may be expected to increase impulsivity and the risk of
gambling problems, based on correlation studies (Clarke, 2006).
Another explanation for the lack of observations of gambling
problems in HD may be related to differences in underlying
neuropathology. While the cognitive disturbances appear to be
highly similar between pathological gamblers and HD patients,
the emotional changes are of a different nature. Pathological
gamblers mainly show an increased sensitivity to rewards, urging
them to start and continue gambling. HD, on the other hand,
has been associated with a decreased sensitivity to punishments
and negative emotions. This difference may be an important
reason why HD patients do not appear to have an increased
tendency to start gambling or engage in other rewarding, addictive
behaviors.
Nevertheless, disturbances in the limbic cortico-striatal circuit
of HD patients may still promote risky decision-making in situa-
tions with uncertain outcome, as demonstrated in the IGT (Doya,
2008). Moreover, the combination of decreased sensitivity to
punishment, failure to inhibit impulsive responses to immediate
rewards, and inability to consider long-term delayed rewards and
enforce advantageous behavioral patterns accordingly, makes it
likely for HD patients to develop gambling problems, when they
encounter a situation that promotes such behavior. Characteristic
problems of HD patients with strategy shifting and symptoms
of cognitive inflexibility and perseveration may contribute to the
progression of pathological behavior in these situations. Thus,
we propose that HD patients do not have an increased ten-
dency to start gambling or other addictive behaviors inherent
to their neuropathology, but that they do have an increased risk
of developing an addiction once they engage in gambling. In
accordance with this idea, it has been observed that frontal lesion
patients become impulsive and often make poor decisions, but
that they do not exhibit increased risk-taking behavior (Miller,
1992; Bechara et al., 2000). This suggests that impaired decision-
making and risk-taking or -seeking behavior do not necessarily
occur together, and that different combinations of limbic and
associative/cognitive control circuit disturbances can have differ-
ent effects on risky-decision making and gambling behavior. Our
hypothesis would also explain why HD patients have not been
observed to perform worse on the CGT. Since all information
about chances and values of wins and losses is available up
front in this task, HD patients may not develop disadvantageous
strategies, because they are not actively seeking risks. However,
this would need to be tested in more advanced disease patients.
If HD patients indeed have an increased risk of developing
pathological gambling behavior when presented with the appro-
priate situation, the rise of easily accessible Internet gambling
opportunities may pose a specific risk for this patient group. Even
if they do not actively seek out these situations, HD patients are
now much more likely to come across gambling opportunities
than they were in the past. This is especially true for patients who
spend most of their time at home due to their symptoms, where
the Internet may be an important means to occupy them. A higher
probability of engaging in gambling behavior may therefore cause
a disproportionate increase in related problems in the HD popula-
tion. We suggest that caretakers should be aware of these possible
risks, and preferably try to prevent HD patients from engaging in
(online) gambling activities. Moreover, we argue that clinicians
should regularly assess the risk and prevalence of gambling-
related problems in the HD population, to be able to provide
appropriate treatment and guidance to patients and caretakers.
FUTURE DIRECTIONS
Besides epidemiological studies to assess the prevalence of patho-
logical gambling and other addictions in HD, several lines of
research can be suggested to increase our understanding of the
issues discussed in this paper. First of all, it would be interesting
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to link performance deficits on the IGT directly to disturbances in
cortico-striatal activity in HD patients. To this end, HD patients’
brain activation patterns can be studied with functional magnetic
resonance imaging while performing the IGT, and compared to
activity in normal subjects. Activity in the striatum, dorsolat-
eral prefrontal cortex and orbitofrontal cortex is expected to be
decreased in HD patients during decision-making on the IGT.
To study the behavioral and neurobiological aspects of
gambling-behavior in HD in more detail, currently available
rodent disease models can be utilized. On a behavioral level,
these animals can be expected to show decreased performance
on the IGT, similar to human patients. Rodent versions of
the IGT are available (review: de Visser et al., 2011) and the
involvement of different neuronal structures in these models is
well characterized (de Visser et al., 2011; van den Bos et al.,
2013a, 2014). Therefore, such experiments are feasible, and can
be combined with in-depth analysis of underlying neuronal
changes in rodent models of HD using a variety of techniques.
Furthermore, with the advent of more ecological valid research
methods and tools to assess the development of pathological
behaviors, the risk for developing pathological gambling may
be studied under (semi)natural conditions in both humans and
animals (van den Bos et al., 2013a). Together, these studies
of gambling-related symptoms and underlying neuropathology
in both human patients and animal models of HD will pro-
vide us with a better understanding of the risks related to
gambling—and possibly other addictive behaviors—in HD, and
improve our ability to provide appropriate treatment and guid-
ance.
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